Therefore, we concluded that miR-532-3p could downregulate PAX5 expression in RCC cells, and according to the TargetScan database, its binding type was summarized as a classical 8mer site (Fig. 6G). This evidence concerns the gene PAX5 and renal cell carcinoma.